Louisiana lawmakers have added two drugs commonly used in pregnancy and reproductive health care to the state’s list of controlled dangerous substances, a move that has alarmed doctors in the state.
FDA approves Servier’s VORANIGO for IGrade 2 glioma
A once-daily oral medication, the asset acts as an inhibitor for both IDH1 and IDH2 enzymes. Credit: danilo.alvesd on Unsplash. The US Food and Drug